Organization
Nagoya University, Nagoya
2 abstracts
Abstract
BASELINE PARAMETERS IDENTIFIED IN EARLY, METHOTREXATE-NAÏVE RHEUMATOID ARTHRITIS PATIENTS WITH BETTER OUTCOMES WITH CERTOLIZUMAB PEGOL+METHOTREXATE COMPARED TO PLACEBO+METHOTREXATE: POST-HOC ANALYSES OF C-OPERA, A RANDOMIZED, CONTROLLED, PHASE 3 SOrg: Hokkaido University Graduate School of Medicine, Hokkaido, The University of Tokyo, Tokyo, Japan, Keio University School of Medicine, Tokyo Women's Medical University, Tokyo, Japan, Nagoya University, Nagoya,
Abstract
BETTER CLINICAL RESPONSES SEEN EARLY WITH THE LOADING DOSE OF CERTOLIZUMAB PEGOL ARE MAINTAINED UNTIL ONE YEAR Org: Keio University School of Medicine, University of Tokyo, Tokyo Women's Medical University, Tokyo, Japan, Nagoya University, Nagoya, University of Occupational and Environmental Health, Kitakyushu, Japan,